Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

被引:0
|
作者
Winter, Stuart S. [1 ]
Devidas, Meenakshi [2 ]
Wood, Brent [3 ]
Borowitz, Michael J. [4 ]
Loh, Mignon L. [5 ]
Asselin, Barbara [6 ]
Murphy, John [7 ]
Raetz, Elizabeth [8 ]
Winick, Naomi [9 ]
Hunger, Stephen [10 ]
Carroll, William [8 ]
Dunsmore, Kimberly [11 ]
机构
[1] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[2] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL USA
[3] Seattle Canc Care Alliance, Seattle, WA USA
[4] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA
[5] Univ Calif San Francisco, Div Pediat Hematol Oncol, San Francisco, CA 94143 USA
[6] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[7] Princess Margaret Hosp Children, Perth, WA, Australia
[8] NYU, Langone Med Ctr, New York, NY USA
[9] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[10] Univ Colorado, Coll Med, Pediat Hem Onc BMT, Aurora, CO USA
[11] Univ Virginia, Charlottesville, VA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:378 / 378
页数:1
相关论文
共 50 条
  • [21] FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children's Cancer Group
    Kumamoto, Tadashi
    Goto, Hiroaki
    Ogawa, Chitose
    Hori, Toshinori
    Deguchi, Takao
    Araki, Takuya
    Saito, Akiko M.
    Manabe, Atsushi
    Horibe, Keizo
    Toyoda, Hidemi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (05) : 720 - 724
  • [22] IMPLEMENTING A LONGITUDINAL PROSPECTIVE STUDY OF FINANCIAL DISTESS IN PARENTS OF CHILDREN WITH NEWLY DIAGNOSED ACUTE LYMPHOBLATIC LEUKEMIA: A REPORT FROM CHILDREN'S ONCOLOGY GROUP
    Beauchemin, Melissa
    Santacroce, Sheila
    Ponce, Olivia
    Ji, Lingyun
    Ramakrishnan, Subhash
    Bona, Kira
    Muneton-Castano, Yudy
    Vargas, Sarah
    Parsons, Susan
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S397 - S397
  • [23] Phase II study of hyper-CVAD followed by nelarabine consolidation in newly diagnosed patients with T cell acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LL).
    Vigil, C. E.
    Kantarjian, H.
    Thomas, D. A.
    O'Brien, S. M.
    Kashani, F. Ravandi
    Koller, C. A.
    Burger, J. A.
    Garris, R. S.
    Baccus, M. D.
    Faderl, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Phase II study of Gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): A Children's Oncology Group report
    Angiolillo, AL
    Whitlock, J
    Chen, Z
    Krailo, M
    Reaman, G
    PEDIATRIC BLOOD & CANCER, 2006, 46 (02) : 193 - 197
  • [25] Correction to: FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children’s Cancer Group
    Tadashi Kumamoto
    Hiroaki Goto
    Chitose Ogawa
    Toshinori Hori
    Takao Deguchi
    Takuya Araki
    Akiko M. Saito
    Atsushi Manabe
    Keizo Horibe
    Hidemi Toyoda
    International Journal of Hematology, 2021, 113 : 308 - 309
  • [26] Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: A report from the Children's Oncology Group
    Termuhlen, Amanda M.
    Smith, Lynette M.
    Perkins, Sherrie L.
    Lones, Mark
    Finlay, Jonathan L.
    Weinstein, Howard
    Gross, Thomas G.
    Abromowitch, Minnie
    PEDIATRIC BLOOD & CANCER, 2012, 59 (07) : 1229 - 1233
  • [27] Area-Based Socioeconomic Disparities in Survival of Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Children's Oncology Group
    Winestone, Lena E.
    Getz, Kelly D.
    Bona, Kira O.
    Fisher, Brian T.
    Gamis, Alan S.
    Seif, Alix E.
    Sung, Lillian
    Wang, Yi-Cheng
    Alonzo, Todd A.
    Aplenc, Richard
    BLOOD, 2019, 134
  • [28] Ten-year survival of children with acute lymphoblastic leukemia: A report from the Children's Oncology Group
    Trigg, Michael E.
    Sather, Harland N.
    Reaman, Gregory H.
    Tubergen, David G.
    Steinherz, Peter G.
    Gaynon, Paul S.
    Uckun, Fatih M.
    Hammond, G. Denman
    LEUKEMIA & LYMPHOMA, 2008, 49 (06) : 1142 - 1154
  • [29] Obesity as a risk factor for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group
    Ghosh, Taumoha
    Richardson, Michaela
    Ryder, Justin
    Spector, Logan
    Turcotte, Lucie
    CANCER RESEARCH, 2019, 79 (13)
  • [30] Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization (vol 36, pg 2926, 2018)
    Winter, Stuart S.
    Dunsmore, Kimberly P.
    Devidas, Meenakshi
    Wood, Brent L.
    Esiashvili, Natia
    Chen, Zhiguo
    Eisenberg, Nancy
    Briegel, Nikki
    Hayashi, Robert J.
    Gastier-Foster, Julie M.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Asselin, Barbara L.
    Gaynon, Paul S.
    Borowitz, Michael J.
    Loh, Mignon L.
    Rabin, Karen R.
    Raetz, Elizabeth A.
    Zweidler-Mckay, Patrick A.
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (09) : 761 - 761